Hypercalcemic nephropathy
- 1 May 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 138 (5) , 777-779
- https://doi.org/10.1001/archinte.138.5.777
Abstract
Hypercalcemia is a frequent electrolyte disturbance, which is most commonly caused by cancer and parathyroid hormone (PTH) disturbances. The mechanisms by which cancer produces hypercalcemia are: direct bone involvement and the production of substances that may accelerate bone resorption. In addition to PTH-like material, 2 such substances are prostaglandins and the so-called osteoclast activating factor, which is a material isolated from malignant cell lines, particularly lymphomas and multiple myeloma. Besides the particular manifestations of the underlying disease, the clinical consequences [humans] of hypercalcemia are the same regardless of the origin.This publication has 7 references indexed in Scilit:
- EFFECT OF ACETAZOLAMIDE AND PARATHYROID-HORMONE ON HCO3 AND PO4 EXCRETION1977
- Vitamin D EndocrinologyAnnals of Internal Medicine, 1976
- Therapy of Fluid and Electrolyte DisordersAnnals of Internal Medicine, 1975
- The mode of inhibition by calcium of cell-membrane adenosine-triphosphatase activityBiochemical Journal, 1966
- Hypercalcemia and HypertensionAnnals of Internal Medicine, 1966
- Calcium Intoxication Due to Primary HyperparathyroidismAnnals of Internal Medicine, 1964
- ION ASSOCIATION. VI. INTERACTIONS BETWEEN CALCIUM, MAGNESIUM, INORGANIC PHOSPHATE, CITRATE AND PROTEIN IN NORMAL HUMAN PLASMA*Journal of Clinical Investigation, 1961